DRC Ebola Crisis: A Faster, Wider Spread

The current Ebola outbreak in the Democratic Republic of Congo has exceeded 10,000 infections, representing a historically rapid and geographically extensive spread. As of October 28, 2026, this outbreak is second only to the West Africa epidemic in terms of fatalities, with nearly 5,000 deaths recorded. Children under five years old are particularly vulnerable, experiencing a mortality rate of approximately 75% among infected.

Factors contributing to the rapid spread include the delayed recognition of the outbreak, which evidence suggests began circulating as early as February or March 2026. The specific strain, Bundibugyo, also presented challenges as initial tests were not calibrated for it. Remote areas and ongoing conflict in northeastern DRC, coupled with potential impacts of reduced foreign aid on surveillance, further complicated early containment efforts.

International cooperation and support have been notably slower compared to previous outbreaks. U.S. policy changes regarding the return of healthcare workers may have limited foreign medical personnel involvement, placing a greater burden on local and regional healthcare staff. Despite funding pledges, health workers report that financial resources are slow to materialize and represent a fraction of previous responses.

Progress has been made with increased diagnostic labs and treatment centers, but a significant challenge remains: two-thirds of deaths occur in the community. This indicates a persistent issue with individuals not seeking care, potentially due to initial mild symptoms or deep-seated community distrust. Rumors and misinformation fuel this distrust, hindering efforts to trace contacts and isolate cases.

Currently, no vaccine or treatment is licensed for the Bundibugyo strain. While an existing vaccine, Ervebo, targets a different species, a clinical trial began in August 2026 to assess its efficacy against Bundibugyo. Experts caution that medical countermeasures alone are insufficient, emphasizing the critical need for sustained international attention, funding, and basic public health measures like contact tracing and isolation to control the escalating crisis.